Analysts’ Viewpoint on Market Scenario
In order to increase the availability of immune-boosting medicines, stakeholders in the global market for cell culture should enter into mergers & acquisitions to make optimum use of financial budgets amid the COVID-19 pandemic. Since FBS is linked with potential risk of disease transmission due to prions, bacteria, or viruses, researchers should adopt alternatives to FBS such as human AB serum and thrombin-activated platelet rich plasma to increase the availability of advanced therapy medicinal products. Moreover, favorable reimbursement programs for individuals in Africa and the Middle East are contributing to the expansion of the market for cell culture. Increase in demand for cost-effective and highly efficient cell culture products such as bioreactors, media, reagents, and sera for the production of high-yield cell lines has led to a rise in the number of new product launches.
Advancements in the cell culture market, in terms of innovations in instruments, media, reagents, and sera are benefitting stakeholders in academic institutes, research centers, biotech companies, and pharmaceutical organizations. Launch of advanced cell culture products and demand for novel therapeutics such as biosimilar are expected to boost the growth of the global market throughout the assessment tenure.
Since cell culture is primarily associated with the diagnosis of infections, testing of new drugs, and other R&D activities, the market is projected to expand at a robust CAGR during the forecast period. The high prevalence of chronic diseases such as cancer, diabetes, renal diseases, and cardiovascular diseases is fueling the demand for cell culture activities to increase the availability of treatment options and therapeutic agents.
The emergence of a new COVID-19 wave in India, China, and the U.K. has brought vaccine companies, biotech companies, and healthcare companies under great scrutiny. In order to win the faith of common individuals and high-risk patients with existing comorbidities, companies in the cell culture market should invest in R&D to innovate and introduce life-saving therapeutics in the market.
Healthcare companies are making use of government stimulus packages and financial schemes provided by the BFSI sector to support research activities in vaccine development and immune-boosting medicines. They should maintain robust supply chains for instruments, sera, media, and reagents to support research activities in academic institutes and biotech companies.
Fetal bovine serum (FBS) is commonly used as a serum-supplement for the in vitro cell culture of eukaryotic cells. However, ethical issues pertaining to FBS is affecting research activities in the global market for cell culture, since fetal bovine serum is derived from the blood drawn from a bovine fetus via a closed system of collection at the slaughterhouse. Hence, researchers are now resorting to alternatives for FBS such as human AB serum and thrombin-activated platelet-rich plasma to excel in cell culture activities.
Alternatives to FBS are becoming necessary, as, in the past years, advanced therapy medicinal products (ATMP) and cell therapy have become increasingly important in terms of clinical use
The high demand for biosimilars and other biologic therapeutics is acting as a key driver for the cell culture industry. This is evident since cell culture helps to increase efficiency & productivity and reduce the cost of manufacture for biologic therapeutics. Healthcare companies are investing in clinical trials to increase the availability of approved biosimilar products. Such advancements are playing an instrumental role in the development of treatment alternatives for chronic diseases in developed as well as developing countries.
Biotech companies are catering to the increase in demand for efficient and cost-effective biosimilars and biologic therapeutics.
Apart from Asia Pacific, companies in the cell culture market are witnessing an increase in the per capita income of individuals in countries of Africa and the Middle East. This improvement in the per capita income can be attributed to rising employment and business opportunities for citizens within the country, and also in countries outside of Africa and the Middle East. Thus, investments toward the development of the healthcare infrastructure in Africa and the Middle East are benefitting stakeholders in the market for cell culture.
In many instances, it has been observed that despite having the income for medical treatments, lack of basic healthcare facilities in rural and remote areas of Africa and the Middle East is affecting patient outcomes. In order to improve patient quality of life, companies should set up biotech companies, research institutes, and academic centers in these regions. These developments are necessary due to high prevalence of rare diseases among the people of Africa and the Middle East.
| Attribute | Detail |
|---|---|
| Market Size Value in 2020 (Base Year) | US$ 10.5 Bn |
| Market Forecast Value in 2031 | US$ 27.6 Bn |
| Growth Rate (CAGR) | 9% |
| Forecast Period | 2021-2031 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes cross segment analysis at regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, pricing analysis, and parent industry overview. |
| Format | Electronic (PDF) |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
Cell Culture Market - Segmentation
TMR’s study on the global market for cell culture includes information divided into three segments: product, end-user, and region. Changing industry trends and other market dynamics associated with these segments of the global market are discussed in detail.
| Attribute | Detail |
|---|---|
| Product |
|
| End-user |
|
| Region |
|
The global market for Cell culture is expected to reach the value of US$ 30 billion by the end of 2028
The global market for cell culture is anticipated to expand at a CAGR of 6.4% from 2021 to 2028
The market is driven by a rise in demand for biopharmaceuticals, an increase in product development by players, and the rapid development of novel vaccines
The instruments segment dominated the global market in 2020 and the trend is projected to continue during the forecast period
Top key players in global market are Thermo Fisher Scientific, Inc., Merck KGaA, GE Healthcare, Lonza Group, Sartorius AG, Becton, Dickinson and Company, Corning, Inc., Eppendorf AG, VWR International, PromoCell GmbH, among others
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Cell Culture Market
4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Cell Culture Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Top 3 players operating in the market space
5.2. Key Mergers & Acquisitions
5.3. Technological Advancements
5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Cell Culture Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value & Volume Forecast, by Product Type, 2017-2031
6.3.1. Instruments
6.3.1.1. Cell Culture Vessels (bioreactor)
6.3.1.2. Carbon Dioxide Incubators
6.3.1.3. Biosafety Cabinets
6.3.1.4. Cryogenic Tanks
6.3.1.5. Others
6.3.2. Media Type
6.3.2.1. Chemically-defined
6.3.2.2. Classical Media
6.3.2.3. Lysogeny Broth (LB)
6.3.2.4. Protein Free
6.3.2.5. Serum Free
6.3.2.6. Specialty Media
6.3.3. Sera
6.3.3.1. Fetal Bovine
6.3.3.2. Newborn Calf
6.3.3.3. Others
6.3.4. Reagents
6.3.4.1. Albumin
6.3.4.2. Amino Acids
6.3.4.3. Attached Factors
6.3.4.4. Growth Factors & Cytokines
6.3.4.5. Protease Inhibitors
6.3.4.6. Thrombin
6.3.4.7. Others
6.4. Market Attractiveness Analysis, by Product Type
7. Global Cell Culture Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value & Volume Forecast, by End-user, 2017-2031
7.3.1. Biotechnology & Pharmaceutical Companies
7.3.2. Academic & Research Institutes
7.3.3. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global Cell Culture Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value & Volume Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Cell Culture Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value & Volume Forecast, by Product Type, 2017-2031
9.2.1. Instruments
9.2.1.1. Cell Culture Vessels (bioreactor)
9.2.1.2. Carbon Dioxide Incubators
9.2.1.3. Biosafety Cabinets
9.2.1.4. Cryogenic Tanks
9.2.1.5. Others
9.2.2. Media Type
9.2.2.1. Chemically-defined
9.2.2.2. Classical Media
9.2.2.3. Lysogeny Broth (LB)
9.2.2.4. Protein Free
9.2.2.5. Serum Free
9.2.2.6. Specialty Media
9.2.3. Sera
9.2.3.1. Fetal Bovine
9.2.3.2. Newborn Calf
9.2.3.3. Others
9.2.4. Reagents
9.2.4.1. Albumin
9.2.4.2. Amino Acids
9.2.4.3. Attached Factors
9.2.4.4. Growth Factors & Cytokines
9.2.4.5. Protease Inhibitors
9.2.4.6. Thrombin
9.2.4.7. Others
9.3. Market Value & Volume Forecast, by End-user, 2017-2031
9.3.1. Biotechnology & Pharmaceutical Companies
9.3.2. Academic & Research Institutes
9.3.3. Others
9.4. Market Value & Volume Forecast, by Country, 2017-2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Product Type
9.5.2. By End-user
9.5.3. By Country
10. Europe Cell Culture Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value & Volume Forecast, by Product Type, 2017-2031
10.2.1. Instruments
10.2.1.1. Cell Culture Vessels (Bioreactor)
10.2.1.2. Carbon Dioxide Incubators
10.2.1.3. Biosafety Cabinets
10.2.1.4. Cryogenic Tanks
10.2.1.5. Others
10.2.2. Media Type
10.2.2.1. Chemically-defined
10.2.2.2. Classical Media
10.2.2.3. Lysogeny Broth (LB)
10.2.2.4. Protein Free
10.2.2.5. Serum Free
10.2.2.6. Specialty Media
10.2.3. Sera
10.2.3.1. Fetal Bovine
10.2.3.2. Newborn Calf
10.2.3.3. Others
10.2.4. Reagents
10.2.4.1. Albumin
10.2.4.2. Amino Acids
10.2.4.3. Attached Factors
10.2.4.4. Growth Factors & Cytokines
10.2.4.5. Protease Inhibitors
10.2.4.6. Thrombin
10.2.4.7. Others
10.3. Market Value & Volume Forecast, by End-user, 2017-2031
10.3.1. Biotechnology & Pharmaceutical Companies
10.3.2. Academic & Research Institutes
10.3.3. Others
10.4. Market Value & Volume Forecast, by Country/Sub-region, 2017-2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Product Type
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Cell Culture Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value & Volume Forecast, by Product Type, 2017-2031
11.2.1. Instruments
11.2.1.1. Cell Culture Vessels (bioreactor)
11.2.1.2. Carbon Dioxide Incubators
11.2.1.3. Biosafety Cabinets
11.2.1.4. Cryogenic Tanks
11.2.1.5. Others
11.2.2. Media Type
11.2.2.1. Chemically-defined
11.2.2.2. Classical Media
11.2.2.3. Lysogeny Broth (LB)
11.2.2.4. Protein Free
11.2.2.5. Serum Free
11.2.2.6. Specialty Media
11.2.3. Sera
11.2.3.1. Fetal Bovine
11.2.3.2. Newborn Calf
11.2.3.3. Others
11.2.3.4. Total
11.2.4. Reagents
11.2.4.1. Albumin
11.2.4.2. Amino Acids
11.2.4.3. Attached Factors
11.2.4.4. Growth Factors & Cytokines
11.2.4.5. Protease Inhibitors
11.2.4.6. Thrombin
11.2.4.7. Others
11.3. Market Value & Volume Forecast, by End-user, 2017-2031
11.3.1. Biotechnology & Pharmaceutical Companies
11.3.2. Academic & Research Institutes
11.3.3. Others
11.4. Market Value & Volume Forecast, by Country/Sub-region, 2017-2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Product Type
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Cell Culture Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value & Volume Forecast, by Product Type, 2017-2031
12.2.1. Instruments
12.2.1.1. Cell Culture Vessels (bioreactor)
12.2.1.2. Carbon Dioxide Incubators
12.2.1.3. Biosafety Cabinets
12.2.1.4. Cryogenic Tanks
12.2.1.5. Others
12.2.2. Media Type
12.2.2.1. Chemically-defined
12.2.2.2. Classical Media
12.2.2.3. Lysogeny Broth (LB)
12.2.2.4. Protein Free
12.2.2.5. Serum Free
12.2.2.6. Specialty Media
12.2.3. Sera
12.2.3.1. Fetal Bovine
12.2.3.2. Newborn Calf
12.2.3.3. Others
12.2.4. Reagents
12.2.4.1. Albumin
12.2.4.2. Amino Acids
12.2.4.3. Attached Factors
12.2.4.4. Growth Factors & Cytokines
12.2.4.5. Protease Inhibitors
12.2.4.6. Thrombin
12.2.4.7. Others
12.3. Market Value & Volume Forecast, by End-user, 2017-2031
12.3.1. Biotechnology & Pharmaceutical Companies
12.3.2. Academic & Research Institutes
12.3.3. Others
12.4. Market Value & Volume Forecast, by Country/Sub-region, 2017-2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Product Type
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Cell Culture Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value & Volume Forecast, by Product Type, 2017-2031
13.2.1. Instruments
13.2.1.1. Cell Culture Vessels (bioreactor)
13.2.1.2. Carbon Dioxide Incubators
13.2.1.3. Biosafety Cabinets
13.2.1.4. Cryogenic Tanks
13.2.1.5. Others
13.2.2. Media Type
13.2.2.1. Chemically-defined
13.2.2.2. Classical Media
13.2.2.3. Lysogeny Broth (LB)
13.2.2.4. Protein Free
13.2.2.5. Serum Free
13.2.2.6. Specialty Media
13.2.3. Sera
13.2.3.1. Fetal Bovine
13.2.3.2. Newborn Calf
13.2.3.3. Others
13.2.4. Reagents
13.2.4.1. Albumin
13.2.4.2. Amino Acids
13.2.4.3. Attached Factors
13.2.4.4. Growth Factors & Cytokines
13.2.4.5. Protease Inhibitors
13.2.4.6. Thrombin
13.2.4.7. Others
13.3. Market Value & Volume Forecast, by End-user, 2017-2031
13.3.1. Biotechnology & Pharmaceutical Companies
13.3.2. Academic & Research Institutes
13.3.3. Others
13.4. Market Value & Volume Forecast, by Country/Sub-region, 2017-2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Product Type
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competition Matrix
14.2. Market Share Analysis, by Company, 2020
14.3. Company Profiles
14.3.1. Thermo Fisher Scientific, Inc.
14.3.1.1. Company Overview
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Strategic Overview
14.3.2. Merck KGaA
14.3.2.1. Company Overview
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Strategic Overview
14.3.3. Cytiva (Danaher Corporation)
14.3.3.1. Company Overview
14.3.3.2. Product Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Strategic Overview
14.3.4. Becton, Dickinson and Company
14.3.4.1. Company Overview
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Strategic Overview
14.3.5. Corning Incorporated
14.3.5.1. Company Overview
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Strategic Overview
14.3.6. Eppendorf SE
14.3.6.1. Company Overview
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Strategic Overview
14.3.7. HiMedia Laboratories
14.3.7.1. Company Overview
14.3.7.2. Product Portfolio
14.3.7.3. SWOT Analysis
14.3.7.4. Strategic Overview
14.3.8. Sartorius AG
14.3.8.1. Company Overview
14.3.8.2. Product Portfolio
14.3.8.3. SWOT Analysis
14.3.8.4. Strategic Overview
14.3.9. FUJIFILM Irvine Scientific, Inc.
14.3.9.1. Company Overview
14.3.9.2. Product Portfolio
14.3.9.3. SWOT Analysis
14.3.9.4. Strategic Overview
14.3.10. InvivoGen
14.3.10.1. Company Overview
14.3.10.2. Product Portfolio
14.3.10.3. SWOT Analysis
14.3.10.4. Strategic Overview
14.3.11. SeraCare (LGC Clinical Diagnostics, Inc.)
14.3.11.1. Company Overview
14.3.11.2. Product Portfolio
14.3.11.3. SWOT Analysis
14.3.11.4. Strategic Overview
14.3.12. Miltenyi Biotec
14.3.12.1. Company Overview
14.3.12.2. Product Portfolio
14.3.12.3. SWOT Analysis
14.3.12.4. Strategic Overview
14.3.13. STEMCELL Technologies, Inc.
14.3.13.1. Company Overview
14.3.13.2. Product Portfolio
14.3.13.3. SWOT Analysis
14.3.13.4. Strategic Overview
14.3.14. Solida Biotech GmbH
14.3.14.1. Company Overview
14.3.14.2. Product Portfolio
14.3.14.3. SWOT Analysis
14.3.14.4. Strategic Overview
14.3.15. Caisson Labs, Inc.
14.3.15.1. Company Overview
14.3.15.2. Product Portfolio
14.3.15.3. SWOT Analysis
14.3.15.4. Strategic Overview
14.3.16. Cellexus
14.3.16.1. Company Overview
14.3.16.2. Product Portfolio
14.3.16.3. SWOT Analysis
14.3.16.4. Strategic Overview
14.3.17. Pierre Guerin
14.3.17.1. Company Overview
14.3.17.2. Product Portfolio
14.3.17.3. SWOT Analysis
14.3.17.4. Strategic Overview
List of Table
Table 01: Global Cell Culture Market Revenue (US$ Mn) Forecast, by Product, 2017-2031
Table 02: Global Cell Culture Market Revenue (US$ Mn) Forecast, by Instruments, 2017-2031
Table 03: Global Cell Culture Market Revenue (US$ Mn) Forecast, by Media, 2017-2031
Table 04: Global Cell Culture Market Revenue (US$ Mn) Forecast, by Sera, 2017-2031
Table 05: Global Cell Culture Market Revenue (US$ Mn) Forecast, by Reagents, 2017-2031
Table 06: Global Cell Culture Market Revenue (US$ Mn) Forecast, by End-user, 2017-2031
Table 07: Global Cell Culture Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 08: North America Cell Culture Market Analysis Value (US$ Mn) Forecast, by Country, 2017-2031
Table 09: North America Cell Culture Market Revenue (US$ Mn) Forecast, by Product, 2017-2031
Table 10: North America Cell Culture Market Revenue (US$ Mn) Forecast, by Instruments, 2017-2031
Table 11: North America Cell Culture Market Revenue (US$ Mn) Forecast, by Media, 2017-2031
Table 12: North America Cell Culture Market Revenue (US$ Mn) Forecast, by Sera, 2017-2031
Table 13: North America Cell Culture Market Revenue (US$ Mn) Forecast, by Reagents, 2017-2031
Table 14: North America Cell Culture Market Revenue (US$ Mn) Forecast, by End-user, 2017-2031
Table 15: Europe Cell Culture Market Analysis Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 16: Europe Cell Culture Market Revenue (US$ Mn) Forecast, by Product, 2017-2031
Table 17: Europe Cell Culture Market Revenue (US$ Mn) Forecast, by Instruments, 2017-2031
Table 18: Europe Cell Culture Market Revenue (US$ Mn) Forecast, by Media, 2017-2031
Table 19: Europe Cell Culture Market Revenue (US$ Mn) Forecast, by Sera, 2017-2031
Table 20: Europe Cell Culture Market Revenue (US$ Mn) Forecast, by Reagents, 2017-2031
Table 21: Europe Cell Culture Market Revenue (US$ Mn) Forecast, by End-user, 2017-2031
Table 22: Asia Pacific Cell Culture Market Value (US$ Mn) Analysis & Forecast, by Country/Sub-region, 2017-2031
Table 23: Asia Pacific Cell Culture Market Revenue (US$ Mn) Forecast, by Product, 2017-2031
Table 24: Asia Pacific Cell Culture Market Revenue (US$ Mn) Forecast, by Instruments, 2017-2031
Table 25: Asia Pacific Cell Culture Market Revenue (US$ Mn) Forecast, by Media, 2017-2031
Table 26: Asia Pacific Cell Culture Market Revenue (US$ Mn) Forecast, by Sera, 2017-2031
Table 27: Asia Pacific Cell Culture Market Revenue (US$ Mn) Forecast, by Reagents, 2017-2031
Table 28: Asia Pacific Cell Culture Market Revenue (US$ Mn) Forecast, by End-user, 2017-2031
Table 29: Latin America Cell Culture Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 30: Latin America Cell Culture Market Revenue (US$ Mn) Forecast, by Product, 2017-2031
Table 31: Latin America Cell Culture Market Revenue (US$ Mn) Forecast, by Instruments, 2017-2031
Table 32: Latin America Cell Culture Market Revenue (US$ Mn) Forecast, by Media, 2017-2031
Table 33: Latin America Cell Culture Market Revenue (US$ Mn) Forecast, by Sera, 2017-2031
Table 34: Latin America Cell Culture Market Revenue (US$ Mn) Forecast, by Reagents, 2017-2031
Table 35: Latin America Cell Culture Market Revenue (US$ Mn) Forecast, by End-user, 2017-2031
Table 36: Middle East & Africa Cell Culture Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 37: Middle East & Africa Cell Culture Market Revenue (US$ Mn) Forecast, by Product, 2017-2031
Table 38: Middle East & Africa Cell Culture Market Revenue (US$ Mn) Forecast, by Instruments, 2017-2031
Table 39: Middle East & Africa Cell Culture Market Revenue (US$ Mn) Forecast, by Media, 2017-2031
Table 40: Middle East & Africa Cell Culture Market Revenue (US$ Mn) Forecast, by Sera, 2017-2031
Table 41: Middle East & Africa Cell Culture Market Revenue (US$ Mn) Forecast, by Reagents, 2017-2031
Table 42: Middle East & Africa Cell Culture Market Revenue (US$ Mn) Forecast, by End-user, 2017-2031
List of Figures
Figure 01: Global Cell Culture Market Value (US$ Mn) Forecast, 2017-2031
Figure 02: Global Cell Culture Market Value Share, by Product, 2020
Figure 03: Global Cell Culture Market Value Share, End-user, 2020
Figure 04: Global Cell Culture Market Attractiveness Analysis, by Product, 2021-2031
Figure 05: Global Cell Culture Market Revenue (US$ Mn), by Instruments, 2017-2031
Figure 06: Global Cell Culture Market Revenue (US$ Mn), by Media, 2017-2031
Figure 07: Global Cell Culture Market Revenue (US$ Mn), by Sera, 2017-2031
Figure 08: Global Cell Culture Market Revenue (US$ Mn), by Reagents, 2017-2031
Figure 09: Global Cell Culture Market Attractiveness Analysis, by Product, 2021-2031
Figure 10: Global Cell Culture Market Attractiveness Analysis, by End-user, 2021-2031
Figure 11: Global Cell Culture Market Revenue (US$ Mn), by Biotechnology & Pharmaceutical Companies, 2017-2031
Figure 12: Global Cell Culture Market Revenue (US$ Mn), by Academic and Research Institutes, 2017-2031
Figure 13: Global Cell Culture Market Revenue (US$ Mn), by Others, 2017-2031
Figure 14: Global Cell Culture Market Attractiveness Analysis, by End-user, 2021-2031
Figure 15: Global Cell Culture Market Attractiveness Analysis, by Region, 2021-2031
Figure 16: Global Cell Culture Market Value Share Analysis, by Region, 2020 and 2031
Figure 17: North America Cell Culture Market Analysis Value (US$ Mn) Forecast, 2017-2031
Figure 18: North America Cell Culture Market Analysis Value Share Analysis, by Country, 2020 and 2031
Figure 19: North America Cell Culture Market Analysis Attractiveness Analysis, by Country 2021-2031
Figure 20: North America Cell Culture Market Attractiveness Analysis, by Product, 2021-2031
Figure 21: North America Cell Culture Market Value Share Analysis, by Product, 2020 and 2031
Figure 22: North America Cell Culture Market Attractiveness Analysis, by End-user, 2021-2031
Figure 23: North America Cell Culture Market Value Share Analysis, by End-user, 2020 and 2031
Figure 24: Europe Cell Culture Market Analysis Value (US$ Mn) Forecast, 2017-2031
Figure 25: Europe Cell Culture Market Analysis Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 26: Europe Cell Culture Market Analysis Attractiveness Analysis, by Country/Sub-region, 2021-2031
Figure 27: Europe Cell Culture Market Attractiveness Analysis, by Technique, 2021-2031
Figure 28: Europe Cell Culture Market Value Share Analysis, by Product, 2020 and 2031
Figure 29: Europe Cell Culture Market Attractiveness Analysis, by End-user, 2021-2031
Figure 30: Europe Cell Culture Market Value Share Analysis, by End-user, 2020 and 2031
Figure 31: Asia Pacific Cell Culture Market Value (US$ Mn) Analysis & Forecast, 2017-2031
Figure 32: Asia Pacific Cell Culture Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 33: Asia Pacific Cell Culture Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
Figure 34: Asia Pacific Cell Culture Market Attractiveness Analysis, by Technique, 2021-2031
Figure 35: Asia Pacific Cell Culture Market Value Share Analysis, by Product, 2020 and 2031
Figure 36: Asia Pacific Cell Culture Market Attractiveness Analysis, by End-user, 2021-2031
Figure 37: Asia Pacific Cell Culture Market Value Share Analysis, by End-user, 2020 and 2031
Figure 38: Latin America Cell Culture Market Value (US$ Mn) Analysis & Forecast, 2017-2031
Figure 39: Latin America Cell Culture Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 40: Latin America Cell Culture Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
Figure 41: Latin America Cell Culture Market Attractiveness Analysis, by Technique, 2021-2031
Figure 42: Latin America Cell Culture Market Value Share Analysis, by Product, 2020 and 2031
Figure 43: Latin America Cell Culture Market Attractiveness Analysis, by End-user, 2021-2031
Figure 44: Latin America Cell Culture Market Value Share Analysis, by End-user, 2020 and 2031
Figure 45: Middle East & Africa Cell Culture Market Value (US$ Mn) Analysis & Forecast, 2017-2031
Figure 46: Middle East & Africa Cell Culture Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 47: Middle East & Africa Cell Culture Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
Figure 48: Middle East & Africa Cell Culture Market Attractiveness Analysis, by Technique, 2021-2031
Figure 49: Middle East & Africa Cell Culture Market Value Share Analysis, by Product, 2020 and 2031
Figure 50: Middle East & Africa Cell Culture Market Attractiveness Analysis, by End-user, 2021-2031
Figure 51: Middle East & Africa Cell Culture Market Value Share Analysis, by End-user, 2020 and 2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Cell Culture Market
